Your browser doesn't support javascript.
loading
Estimating individual lifetime benefit and bleeding risk of adding rivaroxaban to aspirin for patients with stable cardiovascular disease: results from the COMPASS trial.
de Vries, Tamar I; Eikelboom, John W; Bosch, Jackie; Westerink, Jan; Dorresteijn, Jannick A N; Alings, Marco; Dyal, Leanne; Berkowitz, Scott D; van der Graaf, Yolanda; Fox, Keith A A; Visseren, Frank L J.
Afiliação
  • de Vries TI; Department of Vascular Medicine, University Medical Center Utrecht, University Utrecht, GA Utrecht, The Netherlands.
  • Eikelboom JW; Population Health Research Institute, McMaster University and Hamilton Health Sciences, 237 Barton Street East, Hamilton, ON, Canada.
  • Bosch J; Population Health Research Institute, McMaster University and Hamilton Health Sciences, 237 Barton Street East, Hamilton, ON, Canada.
  • Westerink J; Department of Vascular Medicine, University Medical Center Utrecht, University Utrecht, GA Utrecht, The Netherlands.
  • Dorresteijn JAN; Department of Vascular Medicine, University Medical Center Utrecht, University Utrecht, GA Utrecht, The Netherlands.
  • Alings M; Department of Cardiology, Amphia Hospital, Langendijk 75, EV Breda, The Netherlands.
  • Dyal L; Population Health Research Institute, McMaster University and Hamilton Health Sciences, 237 Barton Street East, Hamilton, ON, Canada.
  • Berkowitz SD; Clinical Development, Thrombosis, Bayer U.S. LLC, Whippany, NJ, USA.
  • van der Graaf Y; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, University Utrecht, Universiteitsweg 100, CG Utrecht, The Netherlands.
  • Fox KAA; Centre for Cardiovascular Science, University of Edinburgh, 49 Little France Crescent, Edinburgh, UK.
  • Visseren FLJ; Department of Vascular Medicine, University Medical Center Utrecht, University Utrecht, GA Utrecht, The Netherlands.
Eur Heart J ; 40(46): 3771-3778a, 2019 12 07.
Article em En | MEDLINE | ID: mdl-31504399
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Aspirina / Rivaroxabana / Hemorragia Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Doenças Cardiovasculares / Aspirina / Rivaroxabana / Hemorragia Idioma: En Ano de publicação: 2019 Tipo de documento: Article